Insider Trading History of Vakiener Victoria

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Vakiener Victoria since 2021. This trader's CIK number is 1826263. At the time of last reporting, Vakiener Victoria was the Director of Arrowhead Pharmaceuticals, Inc.. (stock ticker symbol ARWR). Also see all insider trading activities at Arrowhead Pharmaceuticals, Inc..

Note that in the past Vakiener Victoria also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Vakiener Victoria

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 EPZM 0 $0 1,416 $15,992 0 $0

Yearly summary of insider trading at Arrowhead Pharmaceuticals, Inc. (ARWR) by Vakiener Victoria

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ARWR 0 $0 15,513 $420,027 0 $0
2023 ARWR 0 $0 1,550 $40,811 0 $0


Insider trading activities at 2 companies by Vakiener Victoria:

1. Epizyme, Inc. (EPZM)

2. Arrowhead Pharmaceuticals, Inc. (ARWR)

Table 1. Insider trading of Epizyme, Inc. (EPZM) by Vakiener Victoria

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-04 EPZM Sale 817 11.21 9,158
2021-01-25 EPZM Sale 599 11.41 6,834

Table 2. Insider trading of Arrowhead Pharmaceuticals, Inc. (ARWR) by Vakiener Victoria

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-12-16 ARWR Sale 8,994 21.91 197,058
2024-05-02 ARWR Sale 1,799 23.31 41,934
2024-01-11 ARWR Sale 4,720 38.35 181,035
2023-09-28 ARWR Sale 1,550 26.33 40,811

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vakiener Victoria (Director of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.